Canertinib
Information
- Drug Name
- Canertinib
- Description
- Entry(CIViC)
- 2
CIViC
Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
lung non-small cell carcinoma |
EGFR p.Thr790Met (p.T790M) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) EGFR p.Thr790Met (p.T790M) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) |
D |
![]() |
![]() |
Sensitivity/Response | Somatic | 2 | 18408761 | Detail |
lung non-small cell carcinoma |
EGFR p.Leu858Arg (p.L858R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) EGFR p.Leu858Arg (p.L858R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) |
D |
![]() |
![]() |
Sensitivity/Response | Somatic | 18408761 | Detail |
Annotation
Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
---|---|---|---|---|---|---|
In an in vitro study using NCI-H1666 cells (wildty... | EGFR |
EGFR p.Thr790Met (p.T790M) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) EGFR p.Thr790Met (p.T790M) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) |
Sensitivity | true | CIViC Evidence | detail |
In an in vitro study using NCI-H1666 cells (wildty... | EGFR |
EGFR p.Leu858Arg (p.L858R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) EGFR p.Leu858Arg (p.L858R) ( ENST00000275493.7, ENST00000450046.2, ENST00000455089.5 ) |
Sensitivity | true | CIViC Evidence | detail |
- Target (Drug list of Screening Committee of Anticancer Drugs)
- EGFR/Her2
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- CI-1033
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- PD-183805